Table 2.
Pharmacological Agents | Diabetic Nephropathy Models | Phenotypes | References |
---|---|---|---|
Midivi1 (Drp1 inhibitor) |
db/db mice Mouse podocyte |
Decreased p-Drp1 expression Inhibition of mitochondrial fragmentation Decreased ROS production Suppression of renal injury |
[59] |
AICAR & Metformin (PGC-1γ activator) |
Human proximal tubular cell | Inhibition of mitochondrial fragmentation Decreased apoptosis Decreased ROS production Suppression of renal injury |
[79] |
CQ & AQ (AMPK activator) |
STZ-induced mice Human proximal tubular cell |
Decreased Drp1 expression Increased Mfn1 expression Inhibition of mitochondrial fragmentation Decreased apoptosis Decreased ROS production Suppression of renal injury |
[93] |
Sitagliptin (DPP-4 inhibitor) |
STZ-induced mice Human proximal tubular cell |
Decreased Drp1, p-Drp1 expression Increased Mfn2, Opa1 expression Inhibition of mitochondrial fragmentation Recovery of mitochondrial membrane potential Decreased apoptosis Decreased cytochrome c release Decreased ROS production Suppression of renal injury |
[96] |
Formoterol (β2-AR agonist) |
db/db mice Human proximal tubular cell |
Decreased Drp1 expression Increased Mfn1, Mfn2 expression Increased ATP |
[99] |
SS31 (Antioxidant mitochondrial-targeted peptide) |
STZ-induced mice Human proximal tubular cell |
Decreased Drp1 expression Increased Mfn1 expression Inhibition of mitochondrial fragmentation Recovery of mitochondrial membrane potential Decreased apoptosis Decreased ROS production Suppression of renal injury |
[100] |
Melatonin (Mitochondrial-targeted agent) |
ZDF rat | Decreased Drp1 expression Increased Mfn2, Opa1 expression Increased oxygen consumption Increased mitochondrial respiration Suppression of renal injury |
[101] |
Polydatin (Resveratrol glycoside) |
KKAy mice Mouse podocyte |
Decreased p-Drp1 expression Inhibition of mitochondrial fragmentation Decreased apoptosis Decreased ROS production Suppression of renal injury |
[94] |
Empagliflozin (SGLT-2 inhibitor) |
STZ-induced mice KKAy mice Human proximal tubular cell |
Decreased Drp1 expression Increased Mfn1 expression Inhibition of mitochondrial fragmentation Recovery of mitochondrial membrane potential Increased ATP Decreased cytochrome c release Decreased apoptosis Decreased ROS production Suppression of renal injury |
[104,105] |
Berberine (Isoquinoline alkaloid) |
db/db mice Mouse podocyte |
Decreased p-Drp1 expression Inhibition of mitochondrial fragmentation Recovery of mitochondrial membrane potential Increased ATP Decreased apoptosis Decreased ROS production Suppression of renal injury |
[107] |